Brown University Health, Arcamyra Therapeutics to Launch Phase 1 Trial of ACM-CpG for Peritoneal Carcinomatosis jwharton Wed, 08/19/2026 - 10:19 FDA clearance of IND 180703 enables the investigator-initiated BrUOG 452 study led by Khaldoun Almhanna, M.D., at Brown University Health and The Warren Alpert Medical School of Brown University. Brown University Health and Arcamyra Therapeutics Inc., a…